Region D (Noridian) LCD states:
Beneficiaries who fail the initial 12 week trial are eligible to requalify for a PAP device but must have both:
1. Face-to-face clinical re-evaluation by the treating physician to determine the etiology of the failure to respond to PAP therapy;
and,
2. Repeat sleep test in a facility-based setting (Type 1 study).